Kuan-Hung Liu

2 months ago | cmaj.ca | Daniel Tsai |Albert Tzu-Ming Chuang |Kuan-Hung Liu |Shih-Chieh Shao

Mineral and bone disorders (MBD) — characterized by hypocalcemia, hyperphosphatemia, and abnormalities in parathyroid hormone (PTH) and vitamin D metabolism — are observed in 50%–74% of patients with type 2 diabetes mellitus and chronic kidney disease (CKD).1,2 Regular monitoring of biochemical abnormalities and bone diseases in patients with CKD is suggested for early detection of developing CKD-MBD.3 The 2024 American Diabetes Association guideline recommends that adults with type 2...